Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries 23Andme Holding Co. (NQ: ME ) 4.700 +0.050 (+1.08%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about 23Andme Holding Co. < Previous 1 2 3 4 5 6 7 8 9 Next > 23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6 March 20, 2024 From 23andMe, Inc. Via GlobeNewswire 23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago March 19, 2024 Built upon peer-reviewed published science, the Historical Matches feature weaves customers’ ancestral connections into the story of human history and migration From 23andMe, Inc. Via GlobeNewswire A Few Years From Now, You'll Probably Wish You'd Followed Billionaire Investors Into This Stock March 16, 2024 Nu Holdings went from an idea to a $50 billion business over a handful of years. Several billionaire investors are betting on even more upside. Via The Motley Fool Looking Into 23andMe Holding's Recent Short Interest March 04, 2024 Via Benzinga Is 23andMe Stock a Smart Buy Right Now? February 13, 2024 It's having trouble getting its core business model to work. Via The Motley Fool Recap: 23andMe Holding Q3 Earnings February 07, 2024 Via Benzinga 23andMe Launches New Genetic Reports on Common Forms of Cancer March 06, 2024 23andMe customers can now gain deeper insight into their likelihood of developing breast, colorectal, and prostate cancer through new reports based on polygenic risk scores (PRS) developed by 23andMe From 23andMe, Inc. Via GlobeNewswire 23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024 March 05, 2024 23andMe to give an oral presentation on the genetic signature of ULBP6, the target of 23ME-01473, along with poster presentations of the biology of ULBP6 and mechanism of 23ME-01473, and new... From 23andMe, Inc. Via GlobeNewswire Why Intuitive Machines Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket February 26, 2024 Shares of Intuitive Machines, Inc. (NASDAQ: LUNR) fell sharply in today’s pre-market trading. Intuitive Machines revealed Friday that its lunar lander, Odysseus, encountered a mishap during a touchdown... Via Benzinga Earnings Scheduled For February 7, 2024 February 07, 2024 Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million. Via Benzinga A Preview Of 23andMe Holding's Earnings February 06, 2024 Via Benzinga Former YouTube CEO's Teenaged Son Found Dead At UC Berkeley February 18, 2024 The 19-year-old's grandmother, Esther Wojcicki, known as the "Godmother of Silicon Valley," says his death was likely a drug overdose. Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session February 12, 2024 Via Benzinga Crude Oil Gains 3%; Kellanova Posts Upbeat Results February 08, 2024 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 30 points on Thursday. The Dow traded down 0.01% to 38,675.29 while the NASDAQ rose 0.19% to 15,787.09. The... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Dow Tumbles Over 100 Points; US Initial Jobless Claims Fall Last Week February 08, 2024 U.S. stocks traded mixed midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.29% to 38,565.98 while the NASDAQ rose 0.26% to 15,796.91. The... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Thursday's Intraday Session February 08, 2024 Via Benzinga Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 08, 2024 Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results. Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session February 07, 2024 Via Benzinga 23andMe Reports Third Quarter Fiscal 2024 Financial Results February 07, 2024 Announced new non-exclusive data license with GSK, introduced 23andMe Total Health™, and received FDA clearance for IND on novel, dual-mechanism immuno-oncology asset 23ME-1473 From 23andMe, Inc. Via GlobeNewswire Why Is Invitae (NVTA) Stock Down 75% Today? February 05, 2024 Although genetic testing specialist Invitae forwarded a compelling idea, the lack of business substance ultimately cratered NVTA stock. Via InvestorPlace SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy February 05, 2024 Invitae's financial challenges as it grapples with a $1.5 billion debt burden. Explore the company's strategic options amidst potential bankruptcy, asset shedding, and cost-cutting measures. Via Benzinga Topics Bankruptcy Exposures Financial Legal Troubled Biotech Company's Investigational Cancer Drug Gets Greenlighted By FDA January 31, 2024 This development marks a significant milestone for 23andMe, a company that has been in the spotlight for security breaches in the past. Via Benzinga 23andMe Announces FDA Clearance of IND Application for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6 January 31, 2024 From 23andMe, Inc. Via GlobeNewswire 23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay January 30, 2024 “Seat 16” program allows audiences to share the critically acclaimed film with teens across the country From 23andMe, Inc. Via GlobeNewswire 23andMe Faces Class Action Lawsuit Over Alleged Privacy Breach Targeting Chinese And Ashkenazi Jewish Customers January 27, 2024 23andMe faces a class-action lawsuit for a privacy breach affecting 7 million customers, particularly Chinese and Ashkenazi Jewish customers. Via Benzinga Topics Lawsuit Exposures Financial Legal 23andMe to Report FY2024 Third Quarter Financial Results January 24, 2024 From 23andMe, Inc. Via GlobeNewswire The 3 Worst Stock Investments I Ever Made -- and What I Learned From Them January 21, 2024 Not all of my investments have been winners. Here are three that went badly and the important lessons I learned from them. Via The Motley Fool 23andMe announces further expansion of 23ME-00610 Phase 1/2a clinical trial in advanced neuroendocrine and ovarian cancer patient cohorts December 19, 2023 From 23andMe, Inc. Via GlobeNewswire 23andMe Reveals Hackers Accessed 'Significant Number' Of DNA Records December 02, 2023 23andMe confirmed that hackers accessed around 14,000 customer accounts and an undisclosed number of files containing users' ancestry data. Via Benzinga Topics Hacking Exposures Information Security The 3 Best Digital Health Stocks for Personalized Medicine November 25, 2023 Digital health stocks are becoming increasingly relevant as more and more people seek greater control over their health. Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
